share_log

Canaccord Genuity Initiates Coverage On Hims & Hers Health With Buy Rating, Announces Price Target of $20

Moomoo 24/7 ·  Apr 10 07:50

Canaccord Genuity analyst Maria Ripps initiates coverage on Hims & Hers Health (NYSE:HIMS) with a Buy rating and announces Price Target of $20.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment